Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q2 2021 Earnings Conference Call May 6, 2021 4:30 PM ET
Company Participants
Jennifer Viera - Investor Relations
Jay Luly - President and Chief Executive Officer
Paul Mellett - Chief Financial Officer
Nathalie Adda - Chief Medical Officer
Conference Call Participants
Brian Abrahams - RBC Capital Markets
Yasmeen Rahimi - Piper Sandler
Eric Joseph - J.P. Morgan
Roy Buchanan - JMP Securities LLC
Brian Skorney - Robert W. Baird & Co.
William Lee - Wolfe Research, LLC
Zegbeh Jallah - ROTH Capital Partners, LLC
Operator
Good afternoon and welcome to Enanta Pharmaceuticals Fiscal Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end of your prepared remarks. Please be advised that this call is being recorded.
I would now like to turn the call over to Jennifer Viera, Investor Relations. Please go ahead.
Jennifer Viera
Thank you, operator, and thanks to everyone for joining us this afternoon. The news release with our fiscal second quarter financial results was issued this afternoon and is available on our website.
On the call today is Dr. Jay Luly, President and Chief Executive Officer; Paul Mellett, our Chief Financial Officer; and other members of Enanta's senior management team.
Before we begin with our formal remarks, we want to remind you that we will be making forward-looking statements, which may include our plans and expectations with respect to our research and development pipeline and financial projections, all of which involve certain assumptions and risks beyond our control that could cause our actual developments and results to differ materially from those statements.
A description of these risks is in our most recent Form 10-Q and other periodic reports filed with the SEC. Enanta does not undertake any
- Read more current ENTA analysis and news
- View all earnings call transcripts